Daré Bioscience, Inc. (DARE) Social Stream
Dare Bioscience Inc (DARE) Price Targets From Analysts
Use the tables below to see what analysts covering Dare Bioscience Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
DARE's average price target has moved up $0.1 over the prior 144 days.
DARE reports an average of 238.22% for its upside potential over the past 41 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
DARE Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
DARE's average broker recommendation rating improved by 0 over the prior 31 days.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In terms of how Dare Bioscience Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -290.22% of that group.
- In terms of how Dare Bioscience Inc fares relative to all US stocks, note that its average analyst price target is greater than 13.35% of that group.
- In terms of how Dare Bioscience Inc fares relative to stocks in the micro market cap category, note that its number of analysts covering the stock is greater than 364% of that group.
- To contextualize these metrics, consider that out of Healthcare stocks, Dare Bioscience Inc's upside potential (average analyst target price relative to current price) is higher than 273.64% of them.
Is DARE a Buy, Hold or Sell? See the POWR Ratings now!